other analystsThis one is quite long
The key phrase
"they expect to be a partnered phase 3 oncolyogy dvelopper by no later than Fh2024"
"No later than"
Meaning, they could announce tomorrow & take 9 months to get things rolling.
Having a prtnership announcment, being partnered & being a phase 3 developper takes time.
https://leedejonesgable.com/wp-content/uploads/ONC_2022_11_15.pdf
From the report
Accordingly, we expect Oncolytics to be a partnered Phase III-stage oncology biologics developer no later than FH124.
Interesting comaprison tables of other compaines
If you want to do very well in biotech, find the most advanced @ the best discount.
ONC fits that well.